Demonstrating deep knowledge of Myriads liquid and tumor profiling portfolio, including biomarkers, targeted therapies, immuno-oncology, therapy selection pathways, tumor biology, and NGS-based testing. This field based, scientifically focused role supports liquid and tumor profiling across solid tumors, including NGS based assays, biomarker driven therapy selection, resistance mechanisms, and treatment monitoring.